Monthly Archives: December 2011

News: Articles Published During December 2011

These articles were published during the month of December 2011:Air, Soil and Water ResearchEstimating the Pool of Mob…

Lab Notes: Injections That Are ‘Soft as Silk’

(MedPage Today) — Tiny biodegradable needles made of silk protein may one day deliver ouchless injections, researchers suggested. Also in this week’s Lab Notes installment: stem cell wrapping to slow brain cancer.

Washington Week: Medicaid Pays Bonuses to States

WASHINGTON (MedPage Today) — It was a slow healthcare news week in Washington as most of the key players were out of town, but a few nuggets emerged, including a Department of Health and Human Services announcement of Medicaid bonus … Continue reading →

Year in Review: Gene Patent Case May Head to Supreme Court

(MedPage Today) — As part of the Year in Review series, MedPage Today reporters are revisiting major news stories and following up with an analysis of the impact of the original report, as well as subsequent news generated by the … Continue reading →

Year in Review: Court Greenlights Cancer Gene Patent

(MedPage Today) — Our Year in Review series highlights the major medical news stories of 2011. The controversy over whether human genes can be patented was one of the compelling topics that made headlines during the year and here, again, … Continue reading →

Updated GPA Better Predicts Survival With Brain Mets (CME/CE)

(MedPage Today) — The prognosis for cancer patients with brain metastases varies by the type of initial tumor, but the updated Graded Prognostic Assessment tool can help assess survival, researchers reported.

Breast Irradiation Tied to Coronary Stenosis (CME/CE)

(MedPage Today) — Women undergoing radiotherapy for breast cancer are more likely to develop blockages in the areas of their coronary arteries exposed to the most radiation, researchers found.

NSCLC Chemo Rates Unchanged With Early Palliative Care (CME/CE)

(MedPage Today) — Starting a program of palliative care early in the disease course for people with metastatic non-small cell lung cancer did not reduce the level of chemotherapy they received, researchers found.

Bevacizumab Delays Progression of Ovarian Cancer (CME/CE, with audio)

(MedPage Today) — Bevacizumab (Avastin) modestly improved progression-free survival in ovarian cancer, two large randomized trials found.